{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:32:01Z","timestamp":1787063521025,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T00:00:00Z","timestamp":1197504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s12012-007-9009-4","type":"journal-article","created":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T12:35:05Z","timestamp":1197462905000},"page":"41-44","source":"Crossref","is-referenced-by-count":11,"title":["QT Prolongation: A Case of Arsenical Pericardial and Pleural Effusion"],"prefix":"10.1007","volume":"8","author":[{"given":"Enrico","family":"Vizzardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoriana","family":"Zanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Antonioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D\u2019Aloia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Raddino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio Dei","family":"Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,13]]},"reference":[{"key":"9009_CR1","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1200\/JCO.2003.10.009","volume":"21","author":"J. T. Barbey","year":"2003","unstructured":"Barbey, J. T., Pezzullo, J. C., & Soignet, S. L. (2003). Effect of arsenic trioxide on QT interval in patients with advanced malignancies. Journal of Clinical Oncology, 21, 3609\u20133615.","journal-title":"Journal of Clinical Oncology"},{"key":"9009_CR2","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","volume":"89","author":"Z. Shen","year":"1997","unstructured":"Shen, Z., Chen, G., & Ni, J. (1997). Use of arsenic trioxide in the treatment of APL, clinical efficacy and pharmacokinetics in relapsed patients. Blood, 89, 3354\u20133360.","journal-title":"Blood"},{"key":"9009_CR3","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1182\/blood.V94.10.3315.422k16_3315_3324","volume":"94","author":"C. Niu","year":"1999","unstructured":"Niu, C., Yan, H., Yu, T., et\u00a0al. (1999). Studies on treatment of acute promyelocytic leukaemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood, 94, 3315\u20133324.","journal-title":"Blood"},{"key":"9009_CR4","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","volume":"19","author":"S. L. Soignet","year":"2001","unstructured":"Soignet, S. L., Frankel, S. R., Douer, D., et\u00a0al. (2001). United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. Journal of Clinical Oncology, 19, 3852\u20133860.","journal-title":"Journal of Clinical Oncology"},{"key":"9009_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood.V98.2.266","volume":"98","author":"P. Westervelt","year":"2001","unstructured":"Westervelt, P., Brown, R. A., Adkins, D. R., Khoury, H., et\u00a0al. (2001). Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood, 98, 266\u2013271.","journal-title":"Blood"},{"key":"9009_CR6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","volume":"337","author":"M. S. Tallman","year":"1997","unstructured":"Tallman, M. S., Andersen, J. W., Schiffer, C. A., et\u00a0al. (1997). All trans retinoid acid in acute promyelocytic leukemia. The New England Journal of Medicine, 337, 1021\u20131028.","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"9009_CR7","first-page":"251","volume":"2","author":"A. Chanan-Khan","year":"2004","unstructured":"Chanan-Khan, A., Srinivasan, S., & Czuczman, M. S. (2004). Prevention and management of cardiotoxicity from antineoplastic therapy. Journal of Supportive Oncology, 2(3), 251\u2013256.","journal-title":"Journal of Supportive Oncology"},{"issue":"9","key":"9009_CR8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737140.6.9.1249","volume":"6","author":"R. L. Jones","year":"2006","unstructured":"Jones, R. L., & Ewer, M. S. (2006). Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs. Expert Review of Anticancer Therapy, 6(9), 1249\u20131269.","journal-title":"Expert Review of Anticancer Therapy"},{"key":"9009_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.CIR.0000109484.00668.CE","volume":"109","author":"B. Drolet","year":"2004","unstructured":"Drolet, B., Simard, C., & Roden, D. M. (2004). Unusul effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents. Circulation, 109, 26\u201329.","journal-title":"Circulation"},{"key":"9009_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/mdj019","volume":"17","author":"A. Ghavamzade","year":"2006","unstructured":"Ghavamzade, A., Alimoghaddam, K., Ghaffari, S. H., et\u00a0al. (2006). Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and\/or chemotherapy. Annals of Oncology, 17, 131\u2013134.","journal-title":"Annals of Oncology"},{"key":"9009_CR11","first-page":"1851","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"C. D. Klaassen","year":"2001","unstructured":"Klaassen, C. D. (2001). Heavy metals and heavy-metal antagonists. In J. G. Hardman, L. E. Limbird, & G. A. Goodman (Eds.), Goodman & Gilman\u2019s the pharmacological basis of therapeutics (pp. 1851\u20131875). New York: McGraw-Hill."}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-007-9009-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-007-9009-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-007-9009-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T06:55:30Z","timestamp":1588143330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-007-9009-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,13]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9009"],"URL":"https:\/\/doi.org\/10.1007\/s12012-007-9009-4","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,13]]}}}